(Q34594298)

3 August 2017

1 reference

title

Lipases and HDL metabolism (English)

1 reference

3 August 2017

Weijun Jin

1

1 reference

3 August 2017

Dawn Marchadier

series ordinal

2

1 reference

3 August 2017

Daniel J Rader

series ordinal

3

1 reference

3 August 2017

language of work or name

1 reference

1 May 2002

1 reference

Trends in Endocrinology and Metabolism

3 August 2017

published in

1 reference

3 August 2017

volume

13

1 reference

3 August 2017

issue

4

1 reference

3 August 2017

page(s)

174-178

1 reference

Pathophysiology of reverse cholesterol transport. Insights from inherited disorders of lipoprotein metabolism.

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

High-Density Lipoproteins Inhibit Cytokine-Induced Expression of Endothelial Cell Adhesion Molecules

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

Plasma high density lipoproteins. Metabolism and relationship to atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

The tissue-specific expression of lipoprotein lipase: implications for energy and lipoprotein metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

COOH-terminal disruption of lipoprotein lipase in mice is lethal in homozygotes, but heterozygotes have elevated triglycerides and impaired enzyme activity.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

Induced mutant mouse lines that express lipoprotein lipase in cardiac muscle, but not in skeletal muscle and adipose tissue, have normal plasma triglyceride and high-density lipoprotein-cholesterol levels

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

Induced mutant mice expressing lipoprotein lipase exclusively in muscle have subnormal triglycerides yet reduced high density lipoprotein cholesterol levels in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

Lipoprotein lipase gene variants and risk of coronary disease: a quantitative analysis of population-based studies

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

Activities of lipoprotein lipase and hepatic triglyceride lipase in postheparin plasma of patients with low concentrations of HDL cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fasting and postprandial plasma triglycerides: the European Atherosclerosis Research Study (EARS).

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

Suppression of diet-induced atherosclerosis in low density lipoprotein receptor knockout mice overexpressing lipoprotein lipase

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

Overexpression of lipoprotein lipase in transgenic rabbits inhibits diet-induced hypercholesterolemia and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

The novel compound NO-1886 increases lipoprotein lipase activity with resulting elevation of high density lipoprotein cholesterol, and long-term administration inhibits atherogenesis in the coronary arteries of rats with experimental atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

Genetics and molecular biology of hepatic lipase

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

The role of hepatic lipase in lipoprotein metabolism and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

The role of hepatic lipase in lipoprotein metabolism.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

Remodelling of high density lipoproteins by plasma factors

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

Apolipoprotein A-II influences the substrate properties of human HDL2 and HDL3 for hepatic lipase

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

Overexpression of human apolipoprotein A-II in mice induces hypertriglyceridemia due to defective very low density lipoprotein hydrolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

Overexpression of hepatic lipase in transgenic mice decreases apolipoprotein B-containing and high density lipoproteins. Evidence that hepatic lipase acts as a ligand for lipoprotein uptake.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

Hepatic lipase affects both HDL and ApoB-containing lipoprotein levels in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

Overexpression of human hepatic lipase and ApoE in transgenic rabbits attenuates response to dietary cholesterol and alters lipoprotein subclass distributions

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

Hepatic lipase gene therapy in hepatic lipase-deficient mice. Adenovirus-mediated replacement of a lipolytic enzyme to the vascular endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

In vivo evidence for both lipolytic and nonlipolytic function of hepatic lipase in the metabolism of HDL.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

Mild dyslipidemia in mice following targeted inactivation of the hepatic lipase gene

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

Plasma lipoproteins in familial hepatic lipase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

Absence of association between genetic variation in the LIPC gene promoter and plasma lipoproteins in three Canadian populations

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

Hepatic lipase deficiency increases plasma cholesterol but reduces susceptibility to atherosclerosis in apolipoprotein E-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

Erythropoietin gene transfer and expression in adult normal mice: use of an adenovirus vector

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

Reduced HDL2 cholesterol subspecies and elevated postheparin hepatic lipase activity in older men with abdominal obesity and asymptomatic myocardial ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

Low hepatic lipase activity is a novel risk factor for coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

Hepatic lipase as a focal point for the development and treatment of coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

A novel endothelial-derived lipase that modulates HDL metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

Cloning of a unique lipase from endothelial cells extends the lipase gene family

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

Endothelial lipase: a new member of the triglyceride lipase gene family

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

A reassessment of the low molecular weight phospholipase A2 gene family in mammals

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

Overexpression of secretory phospholipase A(2) causes rapid catabolism and altered tissue uptake of high density lipoprotein cholesteryl ester and apolipoprotein A-I

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

Substrate and positional specificities of human and mouse lecithin-cholesterol acyltransferases. Studies with wild type recombinant and chimeric enzymes expressed in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

Lecithin-cholesterol acyltransferase: role in lipoprotein metabolism, reverse cholesterol transport and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

Overexpression of human lecithin cholesterol acyltransferase leads to hyperalphalipoproteinemia in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

Lecithin:cholesterol acyltransferase overexpression generates hyperalpha-lipoproteinemia and a nonatherogenic lipoprotein pattern in transgenic rabbits.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

Potential gene therapy for lecithin-cholesterol acyltransferase (LCAT)-deficient and hypoalphalipoproteinemic patients with adenovirus-mediated transfer of human LCAT gene

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

Hyperalphalipoproteinemia in human lecithin cholesterol acyltransferase transgenic rabbits. In vivo apolipoprotein A-I catabolism is delayed in a gene dose-dependent manner

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

Disruption of the murine lecithin:cholesterol acyltransferase gene causes impairment of adrenal lipid delivery and up-regulation of scavenger receptor class B type I.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

Analysis of glomerulosclerosis and atherosclerosis in lecithin cholesterol acyltransferase-deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

Associations of lecithin: cholesterol acyltransferase (LCAT) mass concentrations with exercise, weight loss, and plasma lipoprotein subfraction concentrations in men.

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

LCAT modulates atherogenic plasma lipoproteins and the extent of atherosclerosis only in the presence of normal LDL receptors in transgenic rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

High plasma HDL concentrations associated with enhanced atherosclerosis in transgenic mice overexpressing lecithin-cholesteryl acyltransferase

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

Overexpression of human lecithin:cholesterol acyltransferase in mice offers no protection against diet-induced atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

Lecithin:cholesterol acyltransferase deficiency increases atherosclerosis in the low density lipoprotein receptor and apolipoprotein E knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS1043-2760%2802%2900589-1

7 January 2021

10.1016/S1043-2760(02)00589-1

Identifiers

DOI

1 reference

3 August 2017

1 reference